Aurinia Pharmaceuticals Inc (AUPH)

09:39 AM

Can Aurinia Pharmaceuticals Inc. (IKAP) stock reach $200 price target2025 Earnings Impact & Short-Term Trading Opportunity Alerts - newser.com

09:39 AM

07:43 AM

Why retail investors pile into Aurinia Pharmaceuticals Inc. stock2025 Key Lessons & Technical Pattern Based Signals - newser.com

07:43 AM

06:27 AM

Can swing trading help recover from Aurinia Pharmaceuticals Inc. lossesJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com

06:27 AM

06:00 AM

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - Yahoo Finance

06:00 AM

Sep 30, 2025

Will earnings trigger a reversal in Aurinia Pharmaceuticals Inc.Market Trend Review & Smart Investment Allocation Insights - newser.com

Sep 30, 2025

Sep 30, 2025

What analysts say about Aurinia Pharmaceuticals Inc stockEconomic Impact on Stocks & Double Digit Profit Strategies - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Aurinia Defends Benefit/Risk Profile of Lupus Nephritis Treatment After FDA Official's Retracted LinkedIn Post - MarketScreener

Sep 30, 2025

Sep 30, 2025

Aurinia Pharma rises after defending lupus drug - TradingView

Sep 30, 2025

Sep 30, 2025

Aurinia Sinks After FDA Official Questions Its Drug in Post - Bloomberg.com

Sep 30, 2025

Sep 30, 2025

Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Sep 30, 2025

Sep 30, 2025

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - MSN

Sep 30, 2025

Sep 30, 2025

How Aurinia Pharmaceuticals Inc. (IKAP) stock compares with top peersQuarterly Portfolio Report & Proven Capital Preservation Methods - newser.com

Sep 30, 2025

Sep 30, 2025

Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD By Investing.com - Investing.com Nigeria

Sep 30, 2025

Sep 29, 2025

Aurinia Responds to Now Retracted LinkedIn Post - Business Wire

Sep 29, 2025

Sep 29, 2025

Pharma company Aurinia falls after FDA official uses LinkedIn to call out lupus drug - Sherwood News

Sep 29, 2025

Sep 29, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week HighHere's Why - MarketBeat

Sep 29, 2025

Sep 29, 2025

Aurinia drops after FDA official criticizes voclosporin - TipRanks

Sep 29, 2025

Sep 29, 2025

Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn - Bloomberg.com

Sep 29, 2025

Sep 29, 2025

Pattern recognition hints at Aurinia Pharmaceuticals Inc. upside2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com

Sep 29, 2025

Sep 29, 2025

Using AI based signals to follow Aurinia Pharmaceuticals Inc.Exit Point & Intraday High Probability Setup Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Smart tools for monitoring Aurinia Pharmaceuticals Inc.’s price actionJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com

Sep 29, 2025

Sep 29, 2025

Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD - Investing.com

Sep 29, 2025

Sep 29, 2025

How high can Aurinia Pharmaceuticals Inc. stock goMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com

Sep 29, 2025

Sep 29, 2025

Analyzing net buyer seller activity in Aurinia Pharmaceuticals Inc.2025 Retail Activity & Reliable Volume Spike Trade Alerts - newser.com

Sep 29, 2025

Sep 29, 2025

Will Aurinia Pharmaceuticals Inc. price bounce be sustainableWeekly Trend Summary & Entry Point Confirmation Signals - newser.com

Sep 29, 2025

Sep 27, 2025

Forecasting Aurinia Pharmaceuticals Inc. price range with options dataTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com

Sep 27, 2025

Sep 26, 2025

Is Aurinia Pharmaceuticals Inc a good long term investmentConsumer Goods Stocks & Build Wealth With Strategy - Early Times

Sep 26, 2025

Sep 24, 2025

Strs Ohio Buys New Shares in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Sep 24, 2025

Sep 23, 2025

Aurinia Pharmaceuticals Hits New 52-Week High of $13.44, Up 142% - Markets Mojo

Sep 23, 2025

Sep 23, 2025

Acropolis Investment Management LLC Invests $242,000 in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Sep 23, 2025

Sep 23, 2025

Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD By Investing.com - Investing.com Nigeria

Sep 23, 2025

Sep 23, 2025

Aurinia Pharmaceuticals Hits New 52-Week High of $13.05, Up 140.74% - Markets Mojo

Sep 23, 2025

Sep 22, 2025

Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD - Investing.com India

Sep 22, 2025

Sep 22, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year HighHere's What Happened - MarketBeat

Sep 22, 2025

Sep 20, 2025

Aurinia Pharmaceuticals stock climbs on insider buying - MSN

Sep 20, 2025

Sep 20, 2025

Does Aurinia Pharmaceuticals Inc. show high probability of reboundJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com

Sep 20, 2025

Sep 19, 2025

Will Aurinia Pharmaceuticals Inc. outperform the marketGlobal Markets & Stepwise Trade Execution Plans - newser.com

Sep 19, 2025

Sep 19, 2025

Does Aurinia Pharmaceuticals Inc. fit your quant trading modelPortfolio Performance Summary & Short-Term High Return Ideas - newser.com

Sep 19, 2025

Sep 19, 2025

Aurinia’s Big Bet On Lupus Nephritis Is Paying Off - Finimize

Sep 19, 2025

Sep 19, 2025

26,155 Shares in Aurinia Pharmaceuticals Inc $AUPH Bought by City Center Advisors LLC - MarketBeat

Sep 19, 2025

Sep 19, 2025

Aug Sentiment: Why is Aurinia Pharmaceuticals Inc. stock going downMarket Performance Report & Weekly Top Performers Watchlists - خودرو بانک

Sep 19, 2025